195 related articles for article (PubMed ID: 11955758)
1. Chemotherapy and altered fractionation in head-and-neck cancer: in regard to Staar et al., IJROBP 2001;50:1161-1171.
Bentzen SM; Bernier J
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1423; author reply 1423-4. PubMed ID: 11955758
[No Abstract] [Full Text] [Related]
2. In regard to Staar et al.: Intensified hyperfractionated accelerated radiotherapy limits the additional benefits of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer. IJROBP 2001;50:1161-1171.
Grabenbauer GG; Sauer R
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):300. PubMed ID: 12183004
[No Abstract] [Full Text] [Related]
3. In regard to Suntharalingam et al. IJROBP 2000;47(1):49-56.
Ochel H
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):281-2. PubMed ID: 11163527
[No Abstract] [Full Text] [Related]
4. Altered fractionation in the treatment of head and neck cancer.
Hu KS; Harrison LB
Curr Oncol Rep; 1999; 1(2):110-23. PubMed ID: 11122807
[TBL] [Abstract][Full Text] [Related]
5. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
Dubben HH; Beck-Bornholdt HP
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
[No Abstract] [Full Text] [Related]
6. Altered fractionation in definitive irradiation of squamous cell carcinoma of the head and neck.
Mendenhall WM; Amdur RJ; Siemann DW; Parsons JT
Curr Opin Oncol; 2000 May; 12(3):207-14. PubMed ID: 10841192
[TBL] [Abstract][Full Text] [Related]
7. Benefits of chemotherapy in head and neck cancer.
Brockstein B
Lancet; 2000 Aug; 356(9231):767-8. PubMed ID: 11085713
[No Abstract] [Full Text] [Related]
8. Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology.
Bernier J; Bentzen SM
Eur J Cancer; 2003 Mar; 39(5):560-71. PubMed ID: 12628834
[TBL] [Abstract][Full Text] [Related]
9. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck.
Mendenhall WM; Riggs CE; Amdur RJ; Hinerman RW; Villaret DB
Laryngoscope; 2003 Mar; 113(3):546-51. PubMed ID: 12616212
[TBL] [Abstract][Full Text] [Related]
10. Correlation of currently used radiobiological parameters with local control and acute and late mucosal toxicity in randomised studies of altered fractionation for locally advanced head and neck cancer.
Hartley A; Sanghera P; Kazi W; Mehanna H; McConkey C; Glaholm J; Fowler J
Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):29-33. PubMed ID: 20829006
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
[TBL] [Abstract][Full Text] [Related]
12. Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010?
Porceddu SV
Asia Pac J Clin Oncol; 2010 Jun; 6(2):75-6. PubMed ID: 20565417
[No Abstract] [Full Text] [Related]
13. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma.
Rosenthal DI; Ang KK
Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy and combined modality therapy in head and neck cancer.
Hamasaki VK; Vokes EE
Curr Opin Oncol; 1993 May; 5(3):508-17. PubMed ID: 8494912
[TBL] [Abstract][Full Text] [Related]
15. New concepts in radiotherapy for advanced squamous cell carcinoma of the head and neck.
Poulsen MG
Aust N Z J Surg; 1992 Sep; 62(9):702-8. PubMed ID: 1520152
[TBL] [Abstract][Full Text] [Related]
16. Concurrent radiation chemotherapy for locally advanced head and neck carcinoma: are we addressing burning subjects?
Ang KK
J Clin Oncol; 2004 Dec; 22(23):4657-9. PubMed ID: 15534361
[No Abstract] [Full Text] [Related]
17. Confirmation of improved local-regional control with altered fractionation in head and neck cancer.
Fowler JF; Harari PM
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):3-6. PubMed ID: 10924965
[No Abstract] [Full Text] [Related]
18. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
Budach W; Hehr T; Budach V; Belka C; Dietz K
BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
[TBL] [Abstract][Full Text] [Related]
19. Altered fractionation in radiotherapy for head and neck cancer: too early to close the race and announce the winner?
Bentzen SM; Dische S
Radiother Oncol; 1999 May; 51(2):105-7. PubMed ID: 10435799
[No Abstract] [Full Text] [Related]
20. Toxicity and outcomes in combined modality treatment of head and neck squamous cell carcinoma: cisplatin versus cetuximab.
Ye AY; Hay JH; Laskin JJ; Wu JS; Ho CC
J Cancer Res Ther; 2013; 9(4):607-12. PubMed ID: 24518704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
